Login / Signup

Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies.

Leila T TchelebiEmma BatchelderMing WangEric J LehrerJoseph J DrabickNavesh SharmaMitchell MachtayDaniel M TrifilettiNicholas G Zaorsky
Published in: JNCI cancer spectrum (2021)
The addition of RTKis to radiotherapy does not improve survival and worsens toxicity.
Keyphrases
  • tyrosine kinase
  • early stage
  • epidermal growth factor receptor
  • locally advanced
  • radiation therapy
  • radiation induced
  • oxidative stress